• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, July 30, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Lithuania joins the EMBO Installation Grants scheme

Bioengineer by Bioengineer
January 23, 2017
in Science News
Reading Time: 2 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

EMBO Programme Manager, Gerlind Wallon, explained, "EMBO Installation Grants encourage talented young group leaders to establish laboratories in countries which might otherwise lose their top scientists abroad. These grants also support the transfer of skills and knowledge from more established research communities to the participating countries. Lithuania is continuing to grow its international profile in the life sciences and we look forward to supporting the foundation of high-quality research groups there."

The EMBO Installation Grants scheme was launched in 2006 and currently offers grants to laboratories in the Czech Republic, Estonia, Poland, Portugal and Turkey, as well as Lithuania. Grants are targeted at scientists who wish to move to these countries and have spent at least two consecutive years working elsewhere.

Professor Virginijus Siksnys, Lithuania's representative at the European Molecular Biology Conference (EMBC), described the positive impact of joining the scheme. "It is a pleasure to see new opportunities for young researchers to establish research facilities in Lithuania," he stated. "The ability to compete with larger economies to attract the finest researchers will help the continued growth of life sciences in our country."

The latest call for applications to the EMBO Installation Grants scheme was made on 20th January 2017. Scientists intending to found new laboratories in one of the eligible countries are encouraged to apply via the EMBO website by 15th April 2017. For more details, see http://www.embo.org/funding-awards/installation-grants

###

About EMBO

EMBO is an organization of more than 1700 leading researchers that promotes excellence in the life sciences. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a European research environment where scientists can achieve their best work.

EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and scientific journals disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science and research policy by seeking input and feedback from our community and by following closely the trends in science in Europe.

For more information: http://www.embo.org

About EMBC

The European Molecular Biology Conference (EMBC) is an intergovernmental organization comprising 29 member states. EMBC promotes a strong transnational approach to the life sciences. Within EMBC, member states pool their resources to improve the quality of research at a national level and to contribute to the advancement of basic research in Europe.

For more information: embc.embo.org

Media Contact

Tilmann Kiessling
[email protected]
49-160-901-93839
@EMBOcomm

http://www.embo.org

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Epigenomic Insights Transform Acute Myeloid Leukemia Outcomes

July 30, 2025
m6A RNA Modification Controls Microglial Phagocytosis in Alzheimer’s

m6A RNA Modification Controls Microglial Phagocytosis in Alzheimer’s

July 30, 2025

Dose of Greenness Linked to Mental Health Benefits

July 30, 2025

Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

July 30, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    58 shares
    Share 23 Tweet 15
  • USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis

    42 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Engineered Cellular Communication Enhances CAR-T Therapy Effectiveness Against Glioblastoma

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Epigenomic Insights Transform Acute Myeloid Leukemia Outcomes

m6A RNA Modification Controls Microglial Phagocytosis in Alzheimer’s

Dose of Greenness Linked to Mental Health Benefits

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.